Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zalutumumab + Radiotherapy in Advanced Head and Neck Cancer
NCT00707655Phase 2Terminated
- Sponsor
- Genmab
- Start
- Sep 2008
- Primary completion
- Oct 2010
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of zalutumumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Genmab. Started Sep 2008; status: terminated.
02
Drugs
zalutumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00707655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707655.